MaaT Pharma SA (EPA:MAAT)
France flag France · Delayed Price · Currency is EUR
6.30
-0.10 (-1.56%)
Apr 2, 2025, 4:11 PM CET

MaaT Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
891118179132-
Upgrade
Market Cap Growth
36.79%36.79%2.32%-40.01%--
Upgrade
Enterprise Value
75975949123-
Upgrade
Last Close Price
6.407.966.988.0013.35-
Upgrade
PS Ratio
34.4534.4536.3555.35135.75-
Upgrade
PB Ratio
-3.962.953.31-
Upgrade
P/TBV Ratio
--4.243.093.38-
Upgrade
EV/Sales Ratio
23.4730.1026.4134.22126.09-
Upgrade
Debt / Equity Ratio
--0.690.420.150.38
Upgrade
Asset Turnover
--0.050.030.03-
Upgrade
Inventory Turnover
--7.4116.05--
Upgrade
Quick Ratio
--2.654.389.937.75
Upgrade
Current Ratio
--2.784.5710.057.76
Upgrade
Return on Equity (ROE)
---83.41%-41.14%-32.33%-92.67%
Upgrade
Return on Assets (ROA)
---28.44%-18.00%-15.08%-20.62%
Upgrade
Return on Capital (ROIC)
---34.28%-20.21%-16.43%-25.55%
Upgrade
Earnings Yield
-32.31%-26.09%-24.34%-17.32%-6.83%-
Upgrade
FCF Yield
--24.40%-16.76%-6.19%-
Upgrade
Buyback Yield / Dilution
--14.89%-307.65%-135.06%-
Upgrade
Updated Sep 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.